| Product Code: ETC9691693 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Parkinsons Disease Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Parkinsons Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Parkinsons Disease Market - Industry Life Cycle |
3.4 Thailand Parkinsons Disease Market - Porter's Five Forces |
3.5 Thailand Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Thailand Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F |
3.7 Thailand Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Thailand Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Thailand Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F |
4 Thailand Parkinsons Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis of Parkinson's disease in Thailand |
4.2.2 Advancements in medical research and technology for Parkinson's disease treatment |
4.2.3 Growing elderly population in Thailand |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare facilities for Parkinson's disease patients in certain regions of Thailand |
4.3.2 High cost of Parkinson's disease treatment and medication |
4.3.3 Lack of trained healthcare professionals specializing in Parkinson's disease management in Thailand |
5 Thailand Parkinsons Disease Market Trends |
6 Thailand Parkinsons Disease Market, By Types |
6.1 Thailand Parkinsons Disease Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Thailand Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Thailand Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F |
6.1.4 Thailand Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F |
6.1.5 Thailand Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F |
6.1.6 Thailand Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F |
6.1.7 Thailand Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F |
6.1.8 Thailand Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F |
6.2 Thailand Parkinsons Disease Market, By Medical Devices |
6.2.1 Overview and Analysis |
6.2.2 Thailand Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F |
6.2.3 Thailand Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F |
6.3 Thailand Parkinsons Disease Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 Thailand Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F |
6.3.4 Thailand Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.5 Thailand Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F |
6.3.6 Thailand Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Parkinsons Disease Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Thailand Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Thailand Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Thailand Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.5 Thailand Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.5 Thailand Parkinsons Disease Market, By Patient Care Setting |
6.5.1 Overview and Analysis |
6.5.2 Thailand Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Thailand Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F |
7 Thailand Parkinsons Disease Market Import-Export Trade Statistics |
7.1 Thailand Parkinsons Disease Market Export to Major Countries |
7.2 Thailand Parkinsons Disease Market Imports from Major Countries |
8 Thailand Parkinsons Disease Market Key Performance Indicators |
8.1 Number of Parkinson's disease awareness campaigns conducted annually in Thailand |
8.2 Percentage increase in Parkinson's disease diagnosis rate year over year in Thailand |
8.3 Number of research studies and clinical trials related to Parkinson's disease conducted in Thailand |
9 Thailand Parkinsons Disease Market - Opportunity Assessment |
9.1 Thailand Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Thailand Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F |
9.3 Thailand Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Thailand Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Thailand Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F |
10 Thailand Parkinsons Disease Market - Competitive Landscape |
10.1 Thailand Parkinsons Disease Market Revenue Share, By Companies, 2024 |
10.2 Thailand Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here